Rheumatoid Arthritis - A Model of Systemic Inflammation Driving Atherosclerosis

被引：133
作者：
Ku, Ivy A. [1 ,2 ]
Imboden, John B. [3 ]
Hsue, Priscilla Y. [1 ,2 ]
Ganz, Peter [1 ,2 ]
机构：
[1] San Francisco Gen Hosp, Div Cardiol, San Francisco, CA 94110 USA
[2] San Francisco Gen Hosp, Ctr Excellence Vasc Res, San Francisco, CA 94110 USA
[3] Univ Calif San Francisco, San Francisco Gen Hosp, Div Rheumatol, San Francisco, CA USA
来源：
CIRCULATION JOURNAL | 2009年 / 73卷 / 06期
关键词：
Atherosclerosis; Coronary artery disease; Inflammation; Rheumatoid arthritis; TUMOR-NECROSIS-FACTOR; ENDOTHELIAL PROGENITOR CELLS; CORONARY-HEART-DISEASE; C-REACTIVE PROTEIN; CARDIOVASCULAR RISK-FACTORS; FACTOR-ALPHA THERAPY; CONVERTING ENZYME-INHIBITION; ACUTE MYOCARDIAL-INFARCTION; HIGH-DENSITY-LIPOPROTEIN; POPULATION-BASED COHORT;
D O I：
10.1253/circj.CJ-09-0274
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Similarities between the inflammatory pathways in atherosclerosis and rheumatoid arthritis (RA) are striking. Chronic systemic inflammation in RA patients leads to cardiovascular (CV) events beyond traditional cardiac risk factors. Clinicians typically focus on treating the joint manifestations of RA while neglecting to eliminate systemic inflammation, which leaves RA patients vulnerable to adverse CV events. In this review we provide an understanding of how systemic inflammation in RA accelerates atherosclerosis. This knowledge should guide therapeutic targets to minimize CV risk in RA, and may lead to insights into the inflammatory mechanisms of atherosclerosis in general. (Circ J 2009; 73: 977-985)
引用
收藏
页码：977 / 985
页数：9
相关论文
共 121 条
[51]   Inhibition of interleukin-1 by anakinra improves vascular and left ventricular function in patients with rheumatoid arthritis [J].
Ikonomidis, Ignatios ;
Lekakis, John P. ;
Nikolaou, Maria ;
Paraskevaidis, Ioannis ;
Andreadou, Ioanna ;
Kaplanoglou, Theophania ;
Katsimbri, Pelagia ;
Skarantavos, Grigorios ;
Soucacos, Panayiotis N. ;
Kremastinos, Dimitrios T. .
CIRCULATION, 2008, 117 (20) :2662-2669
[52]   Novel mechanism for endothelial dysfunction - Dysregulation of dimethylarginine dimethylaminohydrolase [J].
Ito, A ;
Tsao, PS ;
Adimoolam, S ;
Kimoto, M ;
Ogawa, T ;
Cooke, JP .
CIRCULATION, 1999, 99 (24) :3092-3095
[53]  
Jacobsson LTH, 2005, J RHEUMATOL, V32, P1213
[54]  
Kerekes G, 2008, J RHEUMATOL, V35, P398
[55]   Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host [J].
Khovidhunkit, W ;
Kim, MS ;
Memon, RA ;
Shigenaga, JK ;
Moser, AH ;
Feingold, KR ;
Grunfeld, C .
JOURNAL OF LIPID RESEARCH, 2004, 45 (07) :1169-1196
[56]   Endothelial function and coronary artery disease [J].
Kinlay, S ;
Libby, P ;
Ganz, P .
CURRENT OPINION IN LIPIDOLOGY, 2001, 12 (04) :383-389
[57]   ENDOTHELIAL-CELLS STIMULATED WITH TUMOR-NECROSIS-FACTOR-ALPHA EXPRESS VARYING AMOUNTS OF TISSUE FACTOR RESULTING IN INHOMOGENOUS FIBRIN DEPOSITION IN A NATIVE BLOOD-FLOW SYSTEM - EFFECTS OF THROMBIN INHIBITORS [J].
KIRCHHOFER, D ;
TSCHOPP, TB ;
HADVARY, P ;
BAUMGARTNER, HR .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (05) :2073-2083
[58]   Prognostic importance of low body mass index in relation to cardiovascular mortality in rheumatoid arthritis [J].
Kremers, HM ;
Nicola, PJ ;
Crowson, CS ;
Ballman, KV ;
Gabriel, SE .
ARTHRITIS AND RHEUMATISM, 2004, 50 (11) :3450-3457
[59]   Declines in mortality from acute myocardial infarction in successive incidence and birth cohorts of patients with rheumatoid arthritis [J].
Krishnan, E ;
Lingala, VB ;
Singh, G .
CIRCULATION, 2004, 110 (13) :1774-1779
[60]   Case reports of heart failure after therapy with a tumor necrosis factor antagonist [J].
Kwon, HJ ;
Coté, TR ;
Cuffe, MS ;
Kramer, JM ;
Braun, MM .
ANNALS OF INTERNAL MEDICINE, 2003, 138 (10) :807-811
12345678910